Insiders Avalo Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-08 pm EDT			5-day change	1st Jan Change
13.15 ^USD	+4.45%		+4.28%	+44.51%

Jun. 24	Avalo Therapeutics Names Chief Legal Officer	MT
Jun. 24	Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer	CI

Avalo Therapeutics Names Chief Legal Officer	Jun. 24	MT
Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer	Jun. 24	CI
Avalo Therapeutics, Inc. Announces Board Appointments	Mar. 27	CI
Avalo Therapeutics Announces Board Changes	22-08-11	CI
Mind Medicine Names Schond Greenway as CFO	22-05-23	MT
Avalo Therapeutics, Inc. Announces Executive and Board Changes	22-02-18	CI
Avalo Therapeutics Promotes Neil to Chief Executive, Sullivan to Finance Chief	22-02-17	MT
Avalo Therapeutics, Inc. Announces Chief Executive Officer Changes	22-02-17	CI
Avalo Therapeutics, Inc. Announces Resignation of H. Jeffrey Wilkins as Chief Medical Officer	22-02-08	CI
Avalo Therapeutics Appoints Chief Commercial Officer	22-01-11	MT
Avalo Therapeutics, Inc. Appoints Stephen Smolinski as Chief Commercial Officer	22-01-10	CI
Avalo Therapeutics, Inc. Announces Changes to Its Board	21-12-15	CI
Avalo Therapeutics, Inc. Announces Executive Changes	21-12-06	CI
Avalo Therapeutics, Inc. Appoints Keith Maher to the Board	21-10-18	CI
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Cerecor Stock	21-08-18	MT
Insider Trends: Insider Buying Continued with Purchase of Cerecor Stock	21-08-06	MT
Cerecor Inc. Announces Board Changes	21-06-21	CI
Insider Trends: Insider Buying Continued with Purchase of Cerecor Stock	21-05-18	MT
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Cerecor Stock	20-11-25	MT
Cerecor Inc. Appoints Gilla Kaplan, to Its Board of Directors	20-10-12	CI

No results for this search